DEVICE · Unmapped registry intervention
ctDNA-Guided Treatment Strategy
Find medicine records ·
Find other trials using this name
Clinical trial
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NCT07214532
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSignatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Neoplasmsunresolved
Carcinoma, Ductal, Breastunresolved
Interventions
Sponsors & collaborators
Natera, Inc.lead sponsor
Mapped research locations
St LouisMissouri, United States2JacksonvilleFlorida, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1MiamiFlorida, United States1NashvilleTennessee, United States1SeattleWashington, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1IndianapolisIndiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07214532 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.